The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study:

Multiple Sclerosis Journal – Experimental, Translational and Clinical

Mark S Freedman¹  Giancarlo Comi²  Hans-Peter Hartung³  Thomas P Leist⁴  Doris Damian⁵  Patricia K Coyle⁶  Bruce AC Cree⁷  Patrick Vermersch⁸ 

[1] Department of Medicine (Neurology), University of Ottawa and the Ottawa Hospital Research Institute, Canada;Department of Neurology and Institute of Experimental Neurology, Università Vita-Salute San Raffaele, Ospedale San Raffaele, Italy;Department of Neurology, Heinrich Heine University, Medical Faculty, Germany;Division of Clinical Neuroimmunology, Thomas Jefferson University, USA;EMD Serono Inc, 19106EMD Serono Inc, Billerica, USA;Stony Brook University, Department of Neurology, USA;University of California San Francisco, USA;University of Lille, CHU Lille, LIRIC-INSERM U995, FHU Imminent, France

关键词: Cladribine tablets;    clinically isolated syndrome;    conversion to clinically definite multiple sclerosis;    early multiple sclerosis;    efficacy;    McDonald 2010 criteria;   

DOI  :  10.1177/2055217317732802

学科分类：医学（综合）

来源: Sage Journals

【 授权许可】

CC BY-NC